Skip to main content

Comparison of Intrathecal Cilostazol and Nimodipine Treatments in Subarachnoid Hemorrhage: An Experimental Study in Rabbits

  • Conference paper
Early Brain Injury or Cerebral Vasospasm

Part of the book series: Acta Neurochirurgica Supplements ((NEUROCHIRURGICA,volume 110/2))

Abstract

Objective: Intrathecal administration of calcium channel antagonists has been proposed to reduce cerebral vasospasm (CVS) in animal subarachnoid hemorrhage (SAH) models. Also, delayed CVS treatment model with oral administration of cilostazol can be seen in the literature.

Methods: In this study, 25 male New Zealand white rabbits were randomly assigned to five groups: control, SAH only, SAH/nimodipine, SAH/cilostazol, SAH/vehicle. The animals’ basilar arteries were sectioned from four separate zones and four sections were obtained from each rabbit. Basilar artery luminal section areas were measured by using SPOT for windows Version 4.1 computer program.

Results: Basilar artery luminal section areas in SAH/ nimodipine and SAH/ cilostazol groups were significantly higher than SAH only group (P < 0.05).

Conclusion: Phosphodiesterase 3 inhibitor cilostazol has vasodilatory effects without affecting cerebral blood flow. Nimodipine is a calcium channel blocker and is still used in vasospasm therapy either oral or intravenously. This study demonstrates that prophylactic bolus intrathecal administration of either cilostazol or nimodipine equally prevents SAH-associated CVS in an animal model. We therefore propose that cilostazol is a candidate for clinical trials in the treatment of delayed vasospasm.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases.Neurosurgery 2001;48(4):723–8; discussion 728–730.

    PubMed  CAS  Google Scholar 

  2. Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. Am J Neuroradiol. 2004;25(5):819–826.

    PubMed  Google Scholar 

  3. Belen D, Besalti O, Yiğitkanli K, Kösemehmetoğlu K, Simşek S, Bolay H. Leflunomide prevents vasospasm secondary to subarachnoid haemorrhage. Acta Neurochir (Wien). 2007;149(10):1041–7; discussion 1047–1048.

    Article  CAS  Google Scholar 

  4. Bilginer B, Onal MB, Yigitkanli K, Soylemezoglu F, Bavbek M, Ziyal IM, et al. Treatment of cerebral vasospasm with cilostazol in subarachnoid hemorrhage model. Acta Neurochir Suppl. 2008;104:291–295.

    Article  Google Scholar 

  5. Birk S, Kruuse C, Petersen KA, Jonassen O, Tfelt-Hansen P, Olesen J. The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow. J Cereb Blood Flow Metab. 2004;24(12):1352–1358.

    Article  PubMed  CAS  Google Scholar 

  6. Choi JM, Shin HK, Kim KY, Lee JH, Hong KW. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. J Pharmacol Exp Ther. 2002;300(3):787–793.

    Article  PubMed  CAS  Google Scholar 

  7. Conti A, Angileri FF, Longo M, Pitrone A, Granata F, La Rosa G Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report.Acta Neurochir (Wien). 2008;150(11):1197–1202; discussion 1202.

    Article  Google Scholar 

  8. Dawson DL, Cutler BS, Meissner MH, Strandness DE Jr. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial Circulation 1998;18;98(7):678–686.

    Article  PubMed  CAS  Google Scholar 

  9. Dorsch NW Cerebral arterial spasm – a clinical review. Br J Neurosurg. 1995;9(3):403–412.

    Article  PubMed  CAS  Google Scholar 

  10. Firat MM, Gelebek V, Orer HS, Belen D, Firat AK, Balkanci F. Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model. Am J Neuroradiol. 2005;26(6):1357–1362.

    PubMed  Google Scholar 

  11. Gioia AE, White RP, Bakhtian B, Robertson JT. Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm. J Neurosurg. 1985;62(5):721–728.

    Article  PubMed  CAS  Google Scholar 

  12. Gulsen S, Inci S, Yuruk S, Yasar U, Ozgen T. Effect of raloxifene on cerebral vasospasm following experimental subarachnoid hemorrhage in rats. Neurol Med Chir (Tokyo). 2007;47(12):537–542; discussion 542.

    Article  Google Scholar 

  13. Ishida T, Takanashi Y, Kiwada H. Safe and efficient drug delivery system with liposomes for Intrathecal application of an antivasospastic drug, fasudil. Biol Pharm Bull. 2006;29(3):397–402.

    Article  PubMed  CAS  Google Scholar 

  14. Ito H, Fukunaga M, Suzuki H, Miyakoda G, Ishikawa M, Yabuuchi Y, et al. Effect of cilostazol on delayed cerebral vasospasm after subarachnoid hemorrhage in rats: evaluation using black blood magnetic resonance imaging. Neurobiol Dis. 2008;32(1):157–161.

    Article  PubMed  CAS  Google Scholar 

  15. Kim KY, Shin HK, Choi JM, Hong KW. Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells. J Pharmacol Exp Ther. 2002;300(2):709–715.

    Article  PubMed  CAS  Google Scholar 

  16. Komotar RJ, Zacharia BE, Valhora R, Mocco J, Connolly ES Jr. Advances in vasospasm treatment and prevention. J Neurol Sci. 2007;261(1–2):134–142.

    Article  PubMed  CAS  Google Scholar 

  17. Marbacher S, Neuschmelting V, Graupner T, Jakob SM, Fandino J. Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo.Intensive Care Med. 2008;34(5):932–938.

    Article  PubMed  CAS  Google Scholar 

  18. Mayer TE, Dichgans M, Straube A, Birnbaum T, Müller-Schunk S, Hamann GF, et al. Continuous intra-arterial nimodipine for the treatment of cerebral vasospasm. Cardiovasc Intervent Radiol. 2008;31(6):1200–1204.

    Article  PubMed  Google Scholar 

  19. Mori K, Miyazaki M, Iwata J, Yamamoto T, Nakao Y. Intracisternal infusion of magnesium sulfate solution improved reduced cerebral blood flow induced by experimental subarachnoid hemorrhage in the rat. Neurosurg Rev. 2008;31(2):197–203; discussion 203.

    Article  PubMed  Google Scholar 

  20. Moskowitz SI, Ahrens C, Provencio JJ, Chow M, Rasmussen PA. Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage. Surg Neurol. 2009;71(3):311–317, discussion 317–318.

    Article  PubMed  Google Scholar 

  21. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298(6674):636–642.

    Article  PubMed  CAS  Google Scholar 

  22. Seçkin H, Yigitkanli K, Besalti O, Kosemehmetoglu K, Ozturk E, Simsek S, et al. Lamotrigine attenuates cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Surg Neurol. 2008;70(4):344–351; discussion 351.

    Article  PubMed  Google Scholar 

  23. Suzuki M, Doi M, Otawara Y, Ogasawara K, Ogawa A. Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage. Neurosurg Rev. 2001;24(4):180–184.

    Article  PubMed  CAS  Google Scholar 

  24. Takanashi Y, Ishida T, Meguro T, Kirchmeier MJ, Allen TM, Zhang JH. Intrathecal application with liposome-entrapped Fasudil for cerebral vasospasm following subarachnoid hemorrhage in rats. J Clin Neurosci. 2001;8(6):557–561.

    Article  PubMed  CAS  Google Scholar 

  25. Takei K, Tokuyama K, Kato M, Morikawa. A role of cyclic adenosine monophosphate in reducing superoxide anion generation in guinea pig alveolar macrophages. Pharmacology 1998;57(1):1–7.

    Article  PubMed  CAS  Google Scholar 

  26. Tanaka K, Gotoh F, Fukuuchi Y, Amano T, Uematsu D, Kawamura J, et al. Effects of a selective inhibitor of cyclic AMP phosphodiesterase on the pial microcirculation in feline cerebral ischemia. Stroke 1989;20(5):668–673.

    Article  PubMed  CAS  Google Scholar 

  27. Vinall PE, Michele JJ, Gordon DA, Simeone FA. Comparison of intraluminally versus extraluminally administered nimodipine on serotonin-induced cerebral vascular responses in vitro and in situ. Stroke 1989;20(8):1065–1070.

    Article  PubMed  CAS  Google Scholar 

  28. Voldby B, Petersen OF, Buhl M, Jakobsen P, Ostergaard R. Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine).Acta Neurochir (Wien). 1984;70(3–4):243–254.

    Article  CAS  Google Scholar 

  29. Vorkapic P, Bevan JA, Bevan RD. Two indices of functional damage of the artery wall parallel the time course of irreversible narrowing in experimental vasospasm in the rabbit. Blood Vessels 1991;28(1–3):179–182.

    PubMed  CAS  Google Scholar 

  30. Xiong R, Lu W, Li J, Wang P, Xu R, Chen T. Preparation and characterization of intravenously injectable Nimodipine nanosuspension. Int J Pharm. 2008;350(1–2):338–343.

    Article  PubMed  CAS  Google Scholar 

  31. Zabramski J, Spetzler RF, Bonstelle C. Chronic cerebral vasospasm: effect of calcium antagonists. Neurosurgery. 1986;18(2):129–135.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

This study was founded by Turkish Neurosurgery Society.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Bulent Onal .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag/Wien

About this paper

Cite this paper

Onal, M.B., Bilginer, B., Narin, F., Ziyal, M.İ., Soylemezoglu, F., Ozgen, T. (2011). Comparison of Intrathecal Cilostazol and Nimodipine Treatments in Subarachnoid Hemorrhage: An Experimental Study in Rabbits. In: Feng, H., Mao, Y., Zhang, J.H. (eds) Early Brain Injury or Cerebral Vasospasm. Acta Neurochirurgica Supplements, vol 110/2. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0356-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-0356-2_9

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-0355-5

  • Online ISBN: 978-3-7091-0356-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics